Tag: randomised trial

#VisualAbstract SWOG-1211: Addition of elotuzumab to RVd induction and maintenance (lenalidomide, bortezomib, dexamethasone) did not improve patient outcomes in untreated, high-risk multiple myeloma

byKathleen Lau

January 14, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

One dose of human papillomavirus vaccine noninferior to two for preventing persistent infection
Combined Gastric Electrical Stimulation and Pyloroplasty in Gastroparesis
Bisphosphonates may reduce short-term pain in complex regional pain syndrome

No Result

View All Result